SCHEMBL4334690

SCHEMBL4334690

CCOC(=O)CCCCCc1nc(-c2ccccc2)c(-c2ccc(C)cc2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.48
MAPK14 Q16539 1/20 0.44
PTGS2 P35354 1/20 0.44
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPT P10636 1/20 0.43
PPARD Q03181 3/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2B P29275 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4327560 1.00 FAAH (0.48) FAAHMAPK14PTGS2CYP4F2CYP4A11
SCHEMBL4330527 0.96 FAAH (0.52) FAAHPTGS2CYP4F2CYP4A11ALDH1A1
SCHEMBL4329549 0.92 PPARD (0.49) FAAHPTGS2CYP4F2CYP4A11ALDH1A1
SCHEMBL4322242 0.92 PTGS2 (0.54) FAAHMAPK14PTGS2CYP4F2CYP4A11
SCHEMBL4331308 0.92 PPARD (0.49) FAAHPTGS2CYP4F2CYP4A11ALDH1A1
SCHEMBL4332666 0.92 PTGS2 (0.54) FAAHMAPK14PTGS2CYP4F2CYP4A11
SCHEMBL4329770 0.88 RXRA (0.48) MAPK14PTGS2MAPTPPARDHTT
SCHEMBL4341781 0.88 RXRA (0.48) MAPK14PTGS2MAPTPPARDHTT
SCHEMBL4343415 0.84 HDAC1 (0.55)
SCHEMBL4326205 0.84 HDAC1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521563-B2 Hydroxamic acid derivative and medicine containing the same as active ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2009-04-21 US disclosed
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2007-09-06 US disclosed
EP-1787986-A1 HYDROXAMIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIZUOKA COFFEIN CO., LTD. (JP) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient IL6, IL1A, TNF FAAH 2052/4885MAPK14 1240/4885PTGS2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.